Elelyso

Active Ingredient(s): Taliglucerase Alfa
FDA Approved: * May 1, 2012
Pharm Company: * PROTALIX LTD
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Elelyso Overview

Taliglucerase alfa, commercially known as Elelyso, is a biopharmaceutical drug developed by Protalix and Pfizer.[1][2] The drug, a recombinant glucocerebrosidase used to treat Gaucher's disease, was the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration.[3][4] Each vial has 200 units of taliglucerase alfa. For 2016, Elelyso was ranked third for pharmaceuticals with the highest cost-per-patie...

Read more Elelyso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Taliglucerase_alfa

Recent Elelyso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Taliglucerase Alfa
  • Injection: 200 units/vial
  • Powder: 200 units/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Elelyso: (1 result)

Sorted by National Drug Code
  • 0069-0106 Elelyso 200 U/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc

Other drugs which contain Taliglucerase Alfa or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA